Highnoon Laboratories Limited — Investor Relations & Filings
Highnoon Laboratories Limited is a pharmaceutical company focused on the development, production, marketing, and distribution of modern, high-quality, and affordable medicines. Its operations encompass the manufacturing, import, and sale of pharmaceutical and allied consumer products, driven by a commitment to innovative healthcare solutions. The company maintains a robust Research & Development function, dedicated to discovering new treatments and disease prevention. Highnoon's product offerings include specialized medications, such as Feripro Capsule for Thalassemia. Recognized for its ethical marketing, strategic alliances, and strong performance, Highnoon aims to enhance accessibility to its products for patients and the medical community. The company also integrates environmental sustainability and social responsibility into its operations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material Information | 2025-07-29 | English | |
| Change of Chairman | 2025-07-01 | English | |
| Board Meeting Other Then Financial Results | 2025-06-24 | English | |
| Corporate Briefing Session 2024 - Presentation | 2025-06-12 | English | |
| Corporate Briefing Session 2024 - Presentation | 2025-06-11 | English | |
| Miscellaneous InformationREVOKED | 2025-06-11 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 46528383 | Material Information | 2025-07-29 | English | ||
| 46529211 | Change of Chairman | 2025-07-01 | English | ||
| 46529371 | Board Meeting Other Then Financial Results | 2025-06-24 | English | ||
| 46529657 | Corporate Briefing Session 2024 - Presentation | 2025-06-12 | English | ||
| 46529661 | Corporate Briefing Session 2024 - Presentation | 2025-06-11 | English | ||
| 46529666 | Miscellaneous InformationREVOKED | 2025-06-11 | English | ||
| 46529768 | Miscellaneous Information | 2025-06-03 | English | ||
| 46530562 | Credit of Final Cash Dividend | 2025-05-13 | English | ||
| 46530964 | Transmission of Quarterly Report for the Period Ended 2025-03-21 | 2025-04-30 | English | ||
| 46531585 | Miscellaneous Information | 2025-04-29 | English | ||
| 46532538 | Board Meeting | 2025-04-23 | English | ||
| 46533590 | Transmission of Annual Report for the Year Ended 2024 | 2025-04-08 | English | ||
| 46533654 | Transmission of Annual Report for the Year EndedREVOKED | 2025-04-07 | English | ||
| 46533658 | Notice of Annual General Meeting | 2025-04-07 | English | ||
| 46534283 | Board Meeting | 2025-03-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Highnoon Laboratories Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72084/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72084 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72084 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72084 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72084}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Highnoon Laboratories Limited (id: 72084)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.